Cite
HARVARD Citation
Tsoli, M. et al. (2018). Integration of genomics, high throughput drug screening, and personalized xenograft models as a novel precision medicine paradigm for high risk pediatric cancer. Cancer biology & therapy. 19 (12), pp. 1078-1087. [Online].